NCT05705570
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05705570
Title Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies (CARTHIAE-1)
Acronym CARTHIAE-1
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Nelson Hamerschlak
Indications
Therapies
Age Groups: child | adult | senior
Covered Countries BRA


No variant requirements are available.